Blood Culture Test Market Size Worth $17,605.92 Million By 2032 | CAGR: 12.40%

Blood Culture Test Market Size Worth $17,605.92 Million By 2032 | CAGR: 12.40%

The global blood culture test market size is expected to reach USD 17,605.92 million by 2032, according to a new study by Polaris Market Research. The report “Blood Culture Test Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Instruments), By Technique (Conventional, Automated), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing need for more sophisticated and accurate diagnostic techniques for identifying infectious diseases like sepsis is expected to contribute significantly to market growth. In response to this demand, numerous companies operating in the market are directing their efforts toward creating cutting-edge tests that can enhance the effectiveness and precision of diagnostic processes as a whole.

As a result, a growing number of manufacturing firms are concentrating their resources on advancing the development of sophisticated diagnostic instruments and consumables, aiming to provide healthcare professionals with improved tools for accurate and timely disease detection. This trend is driven by the continuous pursuit of better diagnostic capabilities and the potential to enhance patient outcomes through early and accurate diagnosis of infectious diseases.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Regulatory bodies are placing a strong emphasis on enforcing stringent guidelines to ensure the quality and accuracy of diagnostic procedures. For instance, a notable example is CLSI's release of new National Blood Culture guidelines in May 2022, aimed at preventing and minimizing blood culture contaminations. These regulatory measures are expected to play a pivotal role in driving market demand. Additionally, the global surge in COVID-19 infections led to a substantial uptick in the utilization of blood culture tests worldwide, particularly impacting the demand for automated instruments.

Consequently, there exists a substantial surge in the requirement for advanced tools capable of detecting bacterial, fungal, and mycobacterial infections, particularly within hospital settings and clinical diagnostic laboratories. Furthermore, as per data unveiled by the World Health Organization in 2023, the global landscape witnesses a distressing reality where 1 in every six individuals afflicted with bacterial meningitis succumbs annually. Notably, the prevalence of bacterial meningitis remains notably high within sub-Saharan Africa.

Blood Culture Test Market Report Highlights

  • Conventional technique garnered largest share, as this is frequently used option at different end use cases
  • Consumables held the largest share, owing to rise in adoption of blood culture test across different verticals
  • Automated systems will grow at the fastest rate, owing to the development of sophisticated technologically advanced systems
  • APAC will grow at rapid pace, primarily ue to rising cases of infectious diseases, huge patient pool, and improvements in healthcare & pathology infrastructure
  • The global players include BD, Terumo Corporation, Bruker Corporation, bioMerieux, T2 Biosystems, Luminex Corporation, and Abbott Laboratories

Polaris Market Research has segmented the blood culture test market report based on product, technique, technology, application, end use, and regions:

Blood Culture Test, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Consumables
  • Instruments
  • Software & Services

Blood Culture Test, Technique Outlook (Revenue - USD Million, 2019 - 2032)

  • Conventional
  • Automated

Blood Culture Test, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Culture-based Technology
  • Molecular Technology
    • PCR
    • Microarray
    • PNA-FISH
  • Proteomic Technology

Blood Culture Test, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Bacterial Infections
  • Fungal Infections
  • Mycobacterial Infections

Blood Culture Test, End Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospital Laboratories
  • Reference Laboratories
  • Others

Blood Culture Test, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Blood Culture Test Market Report Scope

Report Attributes


Market size value in 2024

USD 6915.74 million

Revenue Forecast in 2032

USD 17,605.92 million


12.40% from 2024 - 2032

Base year


Historical data

2019 - 2022

Forecast period

2024 - 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments Covered

By Product, By Technique, By Technology, By Application, By End Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report